Currently, diagnostic strategies such as serum alpha-fetoprotein (AFP) testing and imaging modalities like ultrasound and MRI are widely used, but they suffer from limited sensitivity and specificity, particularly in early-stage HCC [146]. This evidence concerns the gene AFP and hepatocellular carcinoma.